Publicacións (1.335) Publicacións nas que participase algún/ha investigador/a

2024

  1. A solution to achieve sequencing from SARS-CoV-2 specimens with low viral loads: concatenation of reads from independent reactions

    Virology journal, Vol. 21, Núm. 1, pp. 121

  2. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  3. Activity of cefepime, carbapenems and new β-lactam/β-lactamase inhibitor combinations on Enterobacter cloacae complex and Klebsiella aerogenes in Spain (SMART 2016-2022)

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 3

  4. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    Enfermedades Infecciosas y Microbiologia Clinica

  5. Aspergillus granulosus femoral osteomyelitis in a cardiac transplant patient: first reported case and literature review

    Therapeutic Advances in Infectious Disease, Vol. 11

  6. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

    Infectious Diseases, Vol. 56, Núm. 6, pp. 441-450

  7. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

  8. Characterizing carbapenemase-producing Escherichia coli isolates from Spain: high genetic heterogeneity and wide geographical spread

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  9. Clinical Outcome of Patients with Escherichia coli Isolated from Catheter Lumens and/or Peripheral Blood Cultures: A Retrospective Analysis

    Pathogens, Vol. 13, Núm. 6

  10. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)

    Open Forum Infectious Diseases, Vol. 11, Núm. 3

  11. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

  12. Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

    Mycoses, Vol. 67, Núm. 1

  13. Corrigendum: Tranexamic acid in combination with vancomycin or gentamicin has a synergistic effect against staphylococci (Front. Microbiol., (2023), 13, 935646, 10.3389/fmicb.2022.935646)

    Frontiers in Microbiology

  14. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

  15. Current challenges in acute bacterial skin infection management

    Current opinion in infectious diseases, Vol. 37, Núm. 2, pp. 71-79

  16. Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort

    Open Forum Infectious Diseases, Vol. 11, Núm. 3

  17. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

  18. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

  19. IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

    Infection, Vol. 52, Núm. 3, pp. 813-824

  20. Impact of an interventional bundle on complications associated with peripheral venous catheters in elderly patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 703-712